Takashi Mishima
-
- Pancreatic and Hepatic Oncology Research 14
- Gastroenterology top 10%
-
- Renal cell carcinoma treatment 4
- Gastric Cancer Management and Outcomes 3
-
- Parathyroid Disorders and Treatments 3
-
- Pancreatitis Pathology and Treatment 6
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
-
- Neuroendocrine Tumor Research Advances 6
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Hideaki TsukumaAkira OshimaMasayuki OhtsukaTsukasa TakayashikiShigetsugu TakanoKatsunori FurukawaSatoshi KubokiHideyuki Yoshitomi
In The Last Decade
Takashi Mishima
28 papers receiving 391 citations
Peers
Comparison fields: 5 of 60
- Oncology 165
- Gastroenterology 33
- Pulmonary and Respiratory Medicine 159
- Nephrology 28
- Surgery 162
Countries citing papers authored by Takashi Mishima
This map shows the geographic impact of Takashi Mishima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Mishima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Mishima more than expected).
Fields of papers citing papers by Takashi Mishima
This network shows the impact of papers produced by Takashi Mishima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Mishima. The network helps show where Takashi Mishima may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Takashi Mishima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 4 | |
| 8 | 2021 | 5 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 8 | |
| 11 | 2020 | 24 | |
| 12 | 2020 | 7 | |
| 13 | 2020 | 6 | |
| 14 | 2019 | 40 | |
| 15 | 2019 | 22 | |
| 16 | 2019 | 1 | |
| 17 | 2018 | 1 | |
| 18 | [IV. Distal Pancreatectomy with Celiac Axis Resection(DP-CAR)for Locally Advanced Pancreatic Cancer with Celiac Artery Invasion]. | 2017 | 0 |
| 19 | 2017 | 46 | |
| 20 | 2014 | 20 |
About Takashi Mishima
Takashi Mishima is a scholar working on Oncology, Nephrology and Gastroenterology, having authored 32 papers that have together received 403 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (14 papers), Neuroendocrine Tumor Research Advances (6 papers), Pancreatitis Pathology and Treatment (6 papers), Renal cell carcinoma treatment (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Parathyroid Disorders and Treatments (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (165 citations), Gastroenterology (33 citations) and Pulmonary and Respiratory Medicine (159 citations). Takashi Mishima has collaborated with scholars based in Japan and Egypt. Frequent co-authors include Hideaki Tsukuma, Akira Oshima, Masayuki Ohtsuka, Tsukasa Takayashiki, Shigetsugu Takano, Katsunori Furukawa, Satoshi Kuboki, Hideyuki Yoshitomi, Nozomu Sakai and Hayato Urushima. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, American Journal Of Pathology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.